TALLAHASSEE, Fla. (FNN) – The Florida Department of Health announced monoclonal antibody sites statewide will be closed after the U.S. Food and Drug Administration (FDA) abruptly revoked the drug’s emergency use authorization Monday.
Statement by Governor Ron DeSantis
Governor Ron DeSantis is demanding the Biden Administration reverse its sudden and reckless decision to revoke emergency use authorization (EUA) for Regeneron and Eli Lilly treatments. This abrupt and unilateral action by the Biden Administration will prevent access to lifesaving treatments for Floridians and Americans.
“Without a shred of clinical data to support this action, Biden has forced trained medical professionals to choose between treating their patients or breaking the law,” said Governor Ron DeSantis. “This indefensible edict takes treatment out of the hands of medical professionals and will cost some Americans their lives. There are real-world implications to Biden’s medical authoritarianism – Americans’ access to treatments is now subject to the whims of a failing president.”
“In our field of medicine, when someone comes to you seeking a treatment that could save their life, it is essential to have treatment options to ensure health care providers can make the best decisions for their patients,” said Surgeon General Dr. Joseph Ladapo. “The Federal Government has failed to adequately provide the United States with adequate outpatient treatment options for COVID-19. Now, they are scrambling to cover up a failure to deliver on a promise to ‘shut down the virus.’”
As a result of this abrupt and clinically unsupported action, the appointments for more than 2,000 Floridians to receive this treatment were canceled on January 25, 2022, alone. This decision was made solely by Biden’s Food and Drug Administration (FDA) without advance warning to states or health providers and without clinical data to support the decision. The deliberate decision by the Biden Administration to make this announcement effective immediately, through a press release, actively prevents states and health care providers from making real-time operational decisions that save lives.
Over the course of the past two years, scientists and researchers across the nation have worked hard to bring us treatments that are both safe and effective. One of these treatments has been monoclonal antibodies. This treatment has saved thousands of lives in Florida and across our nation.